280 related articles for article (PubMed ID: 22052531)
1. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.
Selth LA; Townley S; Gillis JL; Ochnik AM; Murti K; Macfarlane RJ; Chi KN; Marshall VR; Tilley WD; Butler LM
Int J Cancer; 2012 Aug; 131(3):652-61. PubMed ID: 22052531
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as biomarkers of adult Crohn's disease.
Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
5. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
[TBL] [Abstract][Full Text] [Related]
6. Identification of prostate cancer-associated microRNAs in circulation using a mouse model of disease.
Selth LA; Townley SL; Gillis JL; Tilley WD; Butler LM
Methods Mol Biol; 2013; 1024():235-46. PubMed ID: 23719956
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.
Cheng HH; Mitchell PS; Kroh EM; Dowell AE; Chéry L; Siddiqui J; Nelson PS; Vessella RL; Knudsen BS; Chinnaiyan AM; Pienta KJ; Morrissey C; Tewari M
PLoS One; 2013; 8(7):e69239. PubMed ID: 23935962
[TBL] [Abstract][Full Text] [Related]
8. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
9. Circulating MicroRNAs in blood of patients with prostate cancer.
Medina-Villaamil V; Martínez-Breijo S; Portela-Pereira P; Quindós-Varela M; Santamarina-Caínzos I; Antón-Aparicio LM; Gómez-Veiga F
Actas Urol Esp; 2014 Dec; 38(10):633-9. PubMed ID: 24661838
[TBL] [Abstract][Full Text] [Related]
10. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
[TBL] [Abstract][Full Text] [Related]
11. Circulating miRNAs are correlated with tumor progression in prostate cancer.
Brase JC; Johannes M; Schlomm T; Fälth M; Haese A; Steuber T; Beissbarth T; Kuner R; Sültmann H
Int J Cancer; 2011 Feb; 128(3):608-16. PubMed ID: 20473869
[TBL] [Abstract][Full Text] [Related]
12. Weight-reduction through a low-fat diet causes differential expression of circulating microRNAs in obese C57BL/6 mice.
Hsieh CH; Rau CS; Wu SC; Yang JC; Wu YC; Lu TH; Tzeng SL; Wu CJ; Lin CW
BMC Genomics; 2015 Sep; 16(1):699. PubMed ID: 26377847
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions.
Xu Y; Zhang X; Pu S; Wu J; Lv Y; Du D
Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):942-9. PubMed ID: 25274330
[TBL] [Abstract][Full Text] [Related]
14. miRNAs as novel biomarkers in the management of prostate cancer.
Filella X; Foj L
Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free miRNA-141 and miRNA-205 as Prostate Cancer Biomarkers.
Osipov ID; Zaporozhchenko IA; Bondar AA; Zaripov MM; Voytsitskiy VE; Vlassov VV; Laktionov PP; Morozkin ES
Adv Exp Med Biol; 2016; 924():9-12. PubMed ID: 27753010
[TBL] [Abstract][Full Text] [Related]
16. Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer.
Watahiki A; Macfarlane RJ; Gleave ME; Crea F; Wang Y; Helgason CD; Chi KN
Int J Mol Sci; 2013 Apr; 14(4):7757-70. PubMed ID: 23574937
[TBL] [Abstract][Full Text] [Related]
17. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
18. microRNA expression profiling of the developing mouse heart.
Cao L; Kong LP; Yu ZB; Han SP; Bai YF; Zhu J; Hu X; Zhu C; Zhu S; Guo XR
Int J Mol Med; 2012 Nov; 30(5):1095-104. PubMed ID: 22895573
[TBL] [Abstract][Full Text] [Related]
19. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.
Hu J; Wang Z; Liao BY; Yu L; Gao X; Lu S; Wang S; Dai Z; Zhang X; Chen Q; Qiu SJ; Wu Y; Zhu H; Fan J; Zhou J; Wang J
Int J Cancer; 2014 Sep; 135(5):1187-94. PubMed ID: 24488924
[TBL] [Abstract][Full Text] [Related]
20. Detection of microRNAs in prostate cancer cells by microRNA array.
Tang X; Tang X; Gal J; Kyprianou N; Zhu H; Tang G
Methods Mol Biol; 2011; 732():69-88. PubMed ID: 21431706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]